ICAS
DGX icon

Investors Capital Advisory Services’s Quest Diagnostics DGX Stock Holding History

Investors Capital Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,559
Closed -$384K – 713
2014
Q2 		$384K Buy
+6,559
New +$384K 0.06% 415

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Investors Capital Advisory Services's DGX Position: Q3 2014 in Review

Investors Capital Advisory Services sold out of Quest Diagnostics (DGX) in Q3 2014, closing a stake of 6,559 shares — an estimated $384K sold.

Investors Capital Advisory Services first reported a position in DGX in Q2 2014 and held it in 1 quarter. The position peaked at $384K in Q2 2014. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

  • Investors Capital Advisory Services reported no remaining Quest Diagnostics position as of Q3 2014 after selling out during the quarter.
  • Investors Capital Advisory Services sold 6,559 Quest Diagnostics shares in Q3 2014, an estimated $384K.
  • Investors Capital Advisory Services first reported a position in Quest Diagnostics in Q2 2014 and held it in 1 quarter.
  • Investors Capital Advisory Services's Quest Diagnostics position peaked at $384K in Q2 2014.
  • 485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on Investors Capital Advisory Services's 13F filing for Q3 2014, filed 14 Nov 2014.